ImmunoMet Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch ImmunoMet Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of IM156 in Patients With Advanced Solid Tumor and Lymphoma (NCT03272256) | ImmunoMet Therapeutics, Inc. | 2017-10-09 |
Track ImmunoMet Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.